| 产品编号 | CFN96889 | |
| CAS编号 | 1240403-82-0 | |
| 分子式 = 分子量 | C19H20O4 = 312.36 | |
| 产品纯度 | >=98% | |
| 物理属性 | Oil | |
| 化合物类型 | Phenols | |
| 植物来源 | The leaves of Cryptocarya obovata. | |
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 7',8'-Dihydroobolactone | CFN96889 | 1240403-82-0 | 1mg | QQ客服:2056216494 |
| 7',8'-Dihydroobolactone | CFN96889 | 1240403-82-0 | 5mg | QQ客服:2056216494 |
| 7',8'-Dihydroobolactone | CFN96889 | 1240403-82-0 | 10mg | QQ客服:2056216494 |
| 7',8'-Dihydroobolactone | CFN96889 | 1240403-82-0 | 20mg | QQ客服:2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | 7',8'-Dihydroobolactone can inhibit Trypanosoma brucei brucei with an IC(50) of 2.8 microM. | |||
| Targets: | Antifection | |||
| In vitro: |
|
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.2014 mL | 16.0072 mL | 32.0143 mL | 64.0287 mL | 80.0359 mL |
| 5 mM | 0.6403 mL | 3.2014 mL | 6.4029 mL | 12.8057 mL | 16.0072 mL |
| 10 mM | 0.3201 mL | 1.6007 mL | 3.2014 mL | 6.4029 mL | 8.0036 mL |
| 50 mM | 0.064 mL | 0.3201 mL | 0.6403 mL | 1.2806 mL | 1.6007 mL |
| 100 mM | 0.032 mL | 0.1601 mL | 0.3201 mL | 0.6403 mL | 0.8004 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 异戊酸乙酯; Ethyl isovalerate | CFN70021 | 108-64-5 | C7H14O2 = 130.1 | 20mg | QQ客服:215959384 |
| 拉帕替尼; Lapatinib (GW572016) | CFN60025 | 231277-92-2 | C29H26ClFN4O4S = 581.06 | 5mg | QQ客服:3257982914 |
| 异酸浆苦味素G; Isophysalin G | CFN95328 | 152221-21-1 | C28H30O10 = 526.5 | 5mg | QQ客服:3257982914 |
| Valtrate Hydrine B4; Valtrate Hydrine B4 | CFN91785 | 18296-48-5 | C27H40O10 = 524.60 | 5mg | QQ客服:3257982914 |